Molecular Internal Medicine

News


2019


ECCR 2019 - 22nd Annual Meeting of the European Council on Cardiovascular Research, Poiano. Italy
The ECCR Meetings, founded in 1996, provide a unique forum in the field of translational research on blood pressure and cardiovascular disease in Europe for clinical and non-clinical researchers and to foster the translation of novel basic science into best clinical practice. The 22nd Annual Meeting will be held in Poiano, Lago di Garda, Italy, and cover a broad range of subjects relevant to cardiovascular disease. Topic will include arterial hypertension, vascular biology, thrombosis, diabetes, obesity, renal physiology and disease, cardiac biology and disease, and cardiovascular genetics as well as prevention and therapy in cardiovascular disease. Registration and abstract submission open in 2019. The meeting dates will be announced in due time.



ET-16 - The Sixteenth International Conference on Endothelin, Kobe, Japan
The Sixteenth International Conference on Endothelin (ET-16) will be held September 22-25, 2019 in Kobe, Japan, and chaired by Noriaki Emoto, MD PhD, University of Kobe, Kobe, Japan and Bambang Widyantoro, MD PhD, University of Indonesia, Jakarta. The newest in basic and clinical research in the field of endothelin reserach and endothelin receptor antagonism from around the world will be presented. Information about the conference venue, registration, and travel will be available soon.

2018

AHA 2018 - 78th AHA Scientific Sessions, Chicago, IL
AHA Scientific Sessions is the American Heart Association's largest gathering of scientists and healthcare professionals devoted to the science of cardiovascular disease and stroke and the care of patients suffering from these diseases. Programming is designed to improve patient care by communicating the most timely and significant advances in prevention, diagnosis and treatment of cardiovascular disease from many different perspectives. Sessions provide five days of comprehensive, unparalleled education through more than 4,000 presentations given by some of the world’s top leaders in the areas of cardiovascular disease as well as demonstrations of the latest cardiovascular technology and resources. The
conference will be held in Chicago, IL, November 10-12, 2018.


HYPERTENSION 2018 - Scientific Sessions, AHA Council for High Blood Pressure Research, Chicago
The AHA HBPR Scientific Sessions of the American Heart Association Council on Hypertension and the Council on the Kidney in Cardiovascular Disease will take place in Chicago, IL. The program will feature the latest in high blood pressure research and vascular biology and renal medicine from around the globe, including "how-to-sessions" by renowned experts in the field. The meeting will take place September 6-9, 2018.

RRSH 2018 - 11th International Meeting on Rapid Responses to Steroid Hormones, Dublin, Ireland
The 20th anniversary meeting of this international conference will be held in Dublin, Ireland, and chaired by Brian Harvey. The meeting will focus on the most important and recent developments in all areas of steroid hormone action. Abstract submission deadline will be June 2018. The meeting will be held in Dublin, Ireland, from September 4-6, 2018.

ATVB/PVD 2018 - AHA Arteriosclerosis, Thrombosis & Vascular Biology/PVD Scientific Sessions, San Francisco
The meeting will be held in San Francisco, CA, May 10-12, 2018 - sponsored and organized by the AHA Councils on Arteriosclerosis, Thrombosis and Vascular Biology, Peripheral Vascular Disease and Functional Genomics and Translational Biology, and the Society for Vascular Surgery. The
conference will cover multiple disciplines, special lectures and discussion sessions.


2017

AHA 2017 - 77th AHA Scientific Sessions, Anaheim, CA
AHA Scientific Sessions is the American Heart Association's largest gathering of scientists and healthcare professionals devoted to the science of cardiovascular disease and stroke and the care of patients suffering from these diseases. Programming is designed to improve patient care by communicating the most timely and significant advances in prevention, diagnosis and treatment of cardiovascular disease from many different perspectives. Sessions provide five days of comprehensive, unparalleled education through more than 4,000 presentations given by some of the world’s top leaders in the areas of cardiovascular disease as well as demonstrations of the latest cardiovascular technology and resources. The
conference will be held in Anaheim, CA, November 11-15, 2017.

ET-15 - The Fifteenth International Conference on Endothelin, Prague, Czech Republic
The Fifteenth International Conference on Endothelin (ET-15) will be held October 4-7, 2017 in Prague, Czech Republic, and chaired by Dr. Ivana Vaneckova, Czech Academy of Sciences, and Dr. John Pernow, Karolinska Institutet, Stockholm. The newest in basic and clinical research in the field of endothelin reserach and endothelin receptor antagonism from around the world will be presented. Information about the conference venue, registration, and travel will be available shortly (conference program).

Nox Downregulators discovered as a new class of drugs to combat aging, heart failure, and hypertension
A recent report published in "Science Signaling" introducing Nox-downregulators as a new class of drugs to slow down cardiovascular aging and disease featured in Dove Med.

ECCR 2017 - 21st Annual Meeting of the European Council on Cardiovascular Research, Poiano. Italy
The ECCR Meetings, founded in 1996, provide a unique forum in the field of translational research on blood pressure and cardiovascular disease in Europe for clinical and non-clinical researchers and to foster the translation of novel basic science into best clinical practice. The 21th Annual Meeting will be held in Poiano, Lago di Garda, Italy, and cover a broad range of subjects relevant to cardiovascular disease, including hypertension, vascular biology, thrombosis, diabetes, obesity, renal physiology and disease, cardiac biology and disease, and cardiovascular genetics as well as prevention and therapy in cardiovascular disease. Registration and abstract submission opens in May 2017. The meeting will be held October 23-25, 2017.


Discovery of new drug class to combat aging, heart failure, and hypertension featured on KOB4 TV
A recent report published in "Science Signaling" introducing Nox-downregulators as a new class of drugs to slow down cardiovascular aging and disease featured on KOB4 Eyewitness News television.

HYPERTENSION 2017 - Scientific Sessions, AHA Council for High Blood Pressure Research, San Francisco, CA
The AHA HBPR Scientific Sessions of the American Heart Association Council on Hypertension and the Council on the Kidney in Cardiovascular Disease will take place in San Fransciso, CA. The program will feature the latest in high blood pressure research and vascular biology and renal medicine from around the globe, including "how-to-sessions" by renowned experts in the field. The meeting will take place September 13-16, 2017.

ATVB/PVD 2017 - AHA Arteriosclerosis, Thrombosis & Vascular Biology/PVD Scientific Sessions, Minneapolis
The meeting will be held in Minneapolis, MN, May 4-6, 2017 - sponsored and organized by the AHA Councils on Arteriosclerosis, Thrombosis and Vascular Biology, Peripheral Vascular Disease and Functional Genomics and Translational Biology, and the Society for Vascular Surgery - and cover multiple disciplines, special lectures and discussion sessions.


New class of drugs to combat aging diseases discovered
A recent report published in "Science Signaling" introducing Nox-downregulators as a new class of drugs to slow down cardiovascular aging and disease featured in Science Daily.

2016


AHA 2016 - 76th AHA Scientific Sessions, New Orleans, LA
AHA Scientific Sessions is the American Heart Association's largest gathering of scientists and healthcare professionals devoted to the science of cardiovascular disease and stroke and the care of patients suffering from these diseases. Programming is designed to improve patient care by communicating the most timely and significant advances in prevention, diagnosis and treatment of cardiovascular disease from many different perspectives. Sessions provide five days of comprehensive, unparalleled education through more than 4,000 presentations given by some of the world’s top leaders in the areas of cardiovascular disease as well as demonstrations of the latest cardiovascular technology and resources. The
conference will be held in New Orleans, LA, November 13-15, 2016.

MOVD 2016 - 12th International Mechanisms of Vasodilatation, Rochester, MN
The "Symposium on Mechanisms of vasodilatation" (MOVD) will celebrate the 30th anniversary of the discovery of the vasodilator nitric oxide in where it was announced by the later Nobel Laureates Robert F. Furchgott and Louis J. Ignarro at the "IV. International Symposium on the Mechanisms of Vasodilatation" held in June 1986 at the Mayo Clinic, Rochester, MN.
Abstract deadline is February 1, 2016. The anniversary symposium, chaired by Virginia M. Miller and R. Clinton Webb, will again be held at the Mayo Clinic from November 7-9, 2016.

RRSH 2016 - 10th International Meeting on Rapid Responses to Steroid Hormones, Richmond, VA
This international meeting will be held again in the United States and chaired by Barbara D. Boyan of Virginia Commonwealth University, Richmond, Virginia. The meeting will focus on the most important and recent developments in all areas of rapid actions of steroid hormones. Abstract submission deadline is June 15, 2016. The meeting will be held November 2-5, 2016.

ECCR 2016 - 20th Annual Meeting of the European Council on Cardiovascular Research, Poiano. Italy
The ECCR Meetings, founded in 1996, provide a unique forum in the field of translational research on blood pressure and cardiovascular disease in Europe for clinical and non-clinical researchers and to foster the translation of novel basic science into best clinical practice. The 20th Annual Meeting will be held in Poiano, Lago di Garda, Italy, and cover a broad range of subjects relevant to cardiovascular disease, including hypertension, vascular biology, thrombosis, diabetes, obesity, renal physiology and disease, cardiac biology and disease, and cardiovascular genetics as well as prevention and therapy in cardiovascular disease. Registration and abstract submission opens in May 2016. The meeting will be held October 14-16, 2016.


HYPERTENSION 2016 - Scientific Sessions, AHA Council for High Blood Pressure Research, Orlando, FL
The AHA HBPR Scientific Sessions of the American Heart Association Council on Hypertension and the Council on the Kidney in Cardiovascular Disease will take place in Orlando, FL. The program will feature the latest in high blood pressure research and vascular biology and renal medicine from around the globe, including "how-to-sessions" by renowned experts in the field. The meeting will take place September 14-17, 2016,

ESH 2016 - 26th European Meeting on Hypertension and Cardiovascular Protection, Paris
The
26th Meeting of the European Society of Hypertension (ESH) which will be held in Paris, France. Paris has been a pioneer city in the emergence arterial hypertension and cardiovascular research in Europe and has hosted the successful 14th ESH Meeting in Paris in 2004. The annual European Hypertension Meetings offer the highest quality scientific programs related to research in basic and clinic areas in Hypertension with state-of-the-art lectures, satellite symposia, and teaching sessions. The meeting will cover a large area of knowledge in the field not only of hypertension but also of other cardiovascular and metabolic disorders related to hypertension. Submission deadline for late-breaking abstracts is April 29, 2016. The meeting will take place June 10-13, 2016.

ATVB/PVD 2016 - AHA Arteriosclerosis, Thrombosis & Vascular Biology/PVD Scientific Sessions, Nashville, TN
The meeting - sponsored and organized by the AHA Councils on Arteriosclerosis, Thrombosis and Vascular Biology, Peripheral Vascular Disease and Functional Genomics and Translational Biology, and the Society for Vascular Surgery - covers multiple disciplines, special lectures and discussion sessions. The meeting will be held in
Nashville, TN, May 5-7, 2016.

EB 2016 - Experimental Biology Conference, San Diego, CA
The international multidisciplinary life sciences meeting "EB 2016" with nearly 14.000 scientists attending (
Abstract deadline is November 5, 2015) will be held in San Diego, California, April 2-6, 2016.


2015

ANDREAS GRÜNTZIG Foundation established in Zürich 30 years after his death
On the occasion of the 30th anniversary of the death of Andreas Grüntzig, M.D., the ANDREAS GRÜNTZIG Foundation was established at the University of Zürich on October 30, 2015. The foundation promotes and provides support for young talent in training, research, and eduction in vascular medicine and related medical disciplines. The foundation’s activities include the support of clinical training and research in outpatient and inpatient care, and provides support and guidance for next generation physicians and physician-scientists. Further activities of the foundation include information services to the public on the development, prevention, and treatment of vascular diseases and to preserve and maintain the scientific heritage of Andreas Grüntzig. More information at
Gruentzig-Foundation.org.

AHA 2015 - 75th AHA Scientific Sessions, Orlando, FL
AHA Scientific Sessions is the American Heart Association's largest gathering of scientists and healthcare professionals devoted to the science of cardiovascular disease and stroke and the care of patients suffering from these diseases. Programming is designed to improve patient care by communicating the most timely and significant advances in prevention, diagnosis and treatment of cardiovascular disease from many different perspectives. Sessions provide five days of comprehensive, unparalleled education through more than 4,000 presentations given by some of the world’s top leaders in the areas of cardiovascular disease as well as demonstrations of the latest cardiovascular technology and resources. The
conference will be held in Orlando, November 7-11, 2015. Abstract submission closes June 10, 2015

Andreas Grüntzig Memorial Lecture, University of Zurich
In the 1970s,
Andreas Grüntzig at the University of Zurich developed the balloon angioplasty catheter for the treatment of coronary artery and peripheral vascular disease. Today, balloon angioplasty has become the most frequently used medical intervention worldwide. As Grüntzig was denied support in Zürich to further develop his groundbreaking new method, he saw no other option than to leave Switzerland. Grüntzig moved to Emory University in Atlanta, GA in 1980 but died in a plane crash only five years later on October 27, 1985, the cause of which remains unresolved to this day. A memorial lecture («Begabung in der Hochschulmedizin: Gedanken zum 30. Todestag des Zürcher Gefässmediziners Andreas Grüntzig (1939-1985»/«Talent in academic medicine: Reflections on the 30th anniversary of of the death of Zurich vascular physician Andreas Grüntzig (1939-1985)») will be held on October 30, 2015 at the University of Zürich, Grüntzig's former institution, commemorating his untimely death 30 years ago and also reflecting on how universities and politics should deal with and provide support for exceptional talent at their institutions.

HYPERTENSION 2015 - Scientific Sessions, AHA Council for High Blood Pressure Research, Washington, DC
The AHA HBPR scientific sessions of the American Heart Association Council on Hypertension and the Council on the Kidney in Cardiovascular Disease will take place September 16-19, 2015, in Washington, D.C. The program will feature the latest in high blood pressure research and vascular biology and renal medicine from around the globe, including "how-to-sessions" by renowned experts in the field.

ET-14 - The Fourteenth International Conference on Endothelin, Savannah, GA
The Fourteenth International Conference on Endothelin (ET-14) will be held September 2-5, 2015 in Savannah, GA, chaired by Drs. Adviye Ergul, Anil Gulati, and David M. Pollock. The endothelin conferences website offers most up-to-date information on endothelin, the next conference and its scientific program and information about previous endothelin conferences (video with impressions from the Cambridge conference). The conference program of the ET-14 conference is now online, abstract deadline is June 10, 2015

RRSH 2015 - The 9th International Meeting on Rapid Responses to Steroid Hormones, Taiwan
This international meeting will be held in Taipei, Taiwan, June 7-10, 2015. The meeting will focus on the most important and recent developments in all areas of rapid actions of steroid hormones. Abstract submission deadline is April 6, 2015

ATVB/PVD 2015 - AHA Arteriosclerosis, Thrombosis and Vascular Biology / PVD Scientific Sessions, San Francisco, CA
The meeting - sponsored and organized by the AHA Councils on Arteriosclerosis, Thrombosis and Vascular Biology, Peripheral Vascular Disease and Functional Genomics and Translational Biology, and the Society for Vascular Surgery - covers multiple disciplines, special lectures and discussion sessions. It will be held May 7-9, 2015 in San Francisco, CA.
Abstract submission deadline is January 23, 2015

EB 2015 - Experimental Biology Conference, Boston, MA
The international multidisciplinary life sciences meeting "EB 2015" with nearly 14.000 scientists attending will be held in Boston, March 28 - April 1, 2015. Abstract deadline is February 21, 2015.


2014

AHA 2014 - AHA Scientific Sessions, Chicago, IL
AHA Scientific Sessions is the American Heart Association's largest gathering of scientists and healthcare professionals devoted to the science of cardiovascular disease and stroke and the care of patients suffering from these diseases. Programming is designed to improve patient care by communicating the most timely and significant advances in prevention, diagnosis and treatment of cardiovascular disease from many different perspectives. Sessions provide five days of comprehensive, unparalleled education through more than 4,000 presentations given by some of the world’s top leaders in the areas of cardiovascular disease as well as demonstrations of the latest cardiovascular technology and resources. The
conference will be held in Chicago, IL, November 15-19. 2014

HBPR 2014 - Scientific Sessions of the AHA Council for High Blood Pressure Research, San Franscisco, CA
The AHA HBPR scientific sessions of the American Heart Association will take place September 9-12, 2014 in San Francisco, CA, The program will feature the latest in high blood pressure research and vascular biology from around the globe, including four "how-to-sessions" by renowned experts in the fields. Abstract submission closes May 14, 2014, late-breaking abstract deadline closes June 25, 2014.

Medical Summer School for International Health 2014, University "Tor Vergata", Rome
This year's University of Rome Tor Vergata Summer School for medical students will include the modules "International health care: prevention and control of communicable and non-communicable diseases" and "The good and the bad of the immune systems". The Summer School is part of the Lifelong- Learning Policy of the "Education and Culture" theme of the European Commission, and the "ERASMUS Intensive Programme" an will be held at the University of Rome, Tor Vergata, July 22-August 1, 2014. Registration is open until May 23, 2014. Links to memories from the 2011 and the 2012 Summer Schools, for further information go here

EB 2014 - Experimental Biology Conference, San Diego, CA
The international multidisciplinary life sciences meeting "EB 2014" with nearly 14.000 scientists attending will be held at the San Diego Convention Center, San Diego, CA, April 26-30, 2014. Late-breaking abstract deadline is February 21, 2014.

ATVB 2014 - AHA Arteriosclerosis, Thrombosis and Vascular Biology Scientific Sessions, Toronto
The meeting - sponsored and organized by the AHA Councils on Arteriosclerosis, Thrombosis and Vascular Biology, Peripheral Vascular Disease and Functional Genomics and Translational Biology, and the Society for Vascular Surgery - covers multiple disciplines, special lectures and discussion sessions. It will be held May 1-3, in Toronto, Canada. Abstract submission deadline is January 24, 2014.



2013

RRSH 2013 - The 8th International Meeting on Rapid Responses to Steroid Hormones, Erie
This international meeting will be held in Erie, PA, September 19-21, 2013. The meeting will focus on the most important and exciting recent developments in all areas of rapid actions of steroid hormones.


HBPR 2013 - Scientific Sessions of the AHA Council for High Blood Pressure Research, New Orleans
The AHA HBPR scientific sessions of the American Heart Association will take place September 11-14, 2013 in New Orleans, LA. The program will feature the latest in high blood pressure research and vascular biology from around the globe, including four "how-to-sessions" by renowned experts in the fields

ET-13 - The Thirteenth International Conference on Endothelin, Tokyo
The Thirteenth International Conference on Endothelin will be held in September 2013 in Japan, chaired by Drs. Noriaki Emoto and Takashi Miyauchi. The conference will celebrate the 25th anniversary of the discovery of endothelin, the most potent endothelium-derived vasoconstrictor, at the University of Tsukuba in 1988. The conference Chairs'
ET-13 website has the most up-to-date information on the scientific program and the conference. Information about previous conferences is available here, and in a video with impressions from the last ET-12 conference in Cambridge.

IUPS 2013 - 37th World Congress of the International Union of Physiological Sciences, Birmingham
In the 124 years of its tradition (the first World Congress of IUPS was held in 1889 in Basel, Switzerland), the 37th World Congress of the IUPS will be held in Birmingham, UK, July 21-26, 2013. A special
symposium, sponsored by the Federation of European Physiological Sciences (FEBS), will be dedicated to the physiology of rapid responses to estrogens.

Mechanisms and Therapy of Athersclerosis - Special Issue of Current Opinion in Pharmacology published
An issue dedicated solely to atherosclerosis has been published in the journal
Current Opinion in Pharmacology, covering molecular biology, pathology, epidemiology, prevention, clinical consequences and medical therapy of patients with coronary artery disease in more than 20 articles from physicians and scientists, many of whom are world authorities in their field, Courtesy of Elsevier publishers, all articles are available freely online. The articles from this issue can be accessed here.

2013 Karolinska Institutet Summer School, Stockholm, Sweden
This year's Karolinska Summer School is entitled "Sex/Gender aspects in biomedical research", and will be held on Huddinge campus of the Karolinska University Hospital in Stockholm, and will be held from May 27 to May 31, 2013. The Postgraduate Course / Summer School is endorsed by the Centre for Gender Medicine at KI the Postgraduate Program for Developmental Biology and Cellular Signaling.

The 21st Annual Meeting of the Quebéc Society of Hypertension, Montréal
The 21st Annual Meeting of the
Quebéc Society of Hypertension will be held January 16-18, 2013, in association with the Université de Montréal featuring new developments in the pathogenesis and treatment of arterial hypertension. The meeting program and further information are available here.


2012

Endothelin XII - Proceedings of The Twelfth International Conference on Endothelin in Cambridge published
The Proceedings of last year's ET-12 Meeting, the Twelfth International Conference on Endothelin held at Clare's College of the University of Cambridge, UK, have now been published. For the first time in publishing history, the web version of the articles of authors also features videos of the authors' presentation given at the conference that is now part of the online article. The proceedings include peer-reviewed full-length research papers, as well as review articles by the conference's invited speakers. All articles are published Open Access and available online
here.

EB 2012 - Experimental Biology Conference, San Diego
The international multidisciplinary life sciences meeting "EB 2012" with nearly 14.000 scientists attending will be held in San Diego, CA, April 21-25, 2012. The meeting, which includes celebrating the 125
th anniversary of the American Physiological Society, will feature more than 50 concurrent scientific sessions.

Active Development of Careers of Young Scientists: Is Switzerland doing Enough?
On the occasion of the 60th anniversary of the Swiss National Science Foundation a workshop was held in Bern on January 11, 2012, with young scientists participating as well as representatives of the SNSF and the Swiss parliament, discussing the current and future needs for the active development of careers and mentoring (Nachwuchsförderung) of young scientists in Switzerland. The event also featured the first public appearance of the newly elected Federal Counsellor Alain Berset, Head of the Federal Department of Home Affairs of Switzerland (
video in German)


2011

International Cardiovascular Research Funded by the SNSF: Portraits of Young Swiss Scientists
An article by Jennifer Taylor published in Circulation portraying young Swiss researchers in all parts of the world conducting cardiovascular research with support from the Swiss National Science Foundation.

Steve Jobs (1955-2011)
Steven ("Steve") Paul Jobs, father of the "Macintosh" computer, passed away on October 5th, 2011 at age 56. Here are some thoughts of his colleagues on someone who has revolutionized the way we use computers in everyday life, for communication and listening to music (more). Steve Jobs never completed a university eduction, but was enormously gifted with curiosity, creativity, and vision, as well as being a hard worker - all qualities that one will find in a fine scientist. Jobs in fact worked on his "project" until one day before he died. Here are some computer ads deja vues for those many scientists who have worked with Job's products over the years, some views on the reasons for the success of Steve Jobs, a video with Steve Jobs narrating a Macintosh computer commercial, and a video of his commencement address at Stanford University's 114th Commencement given in Stanford Stadium on June 11, 2005, with his advice to the Stanford students "Stay hungry, stay foolish".

RRSH 2011 - The 7th International Meeting on Rapid Responses to Steroid Hormones, Crete
This international meeting will be held in Crete, Greece, September 14-18, 2011. The meeting will focus on the most important and exciting recent developments in the areas of rapid actions of steroid hormones.


ET-12 - The Twelfth International Conference on Endothelin, Cambridge
The Twelfth International Conference on Endothelin will be held at Clare College, Cambridge, September 11-14, 2011. The newest in basic and clinical research in the field of endothelin and endothelin receptor antagonism from around the world will be presented. See the ET-12 conference's High Definition videos of lectures and presentations

Article on Scientific Mentorship featured by American Physician Scientists Association
A recently published portrait on the achievements of Dr. Paul M. Vanhoutte as scientist and mentor has been featured by the American Physician Scientists Association (APSA). The APSA is dedicated to addressing the needs of physician scientists with a focus on training career development. The mission of APSA is to serve as the student physician-scientists' leading voice for improving educational opportunities, advancing patient-oriented research, and advocating for the future of translational medicine.

International Meeting on Endothelium in Health and Disease, London
An international meeting will be held at the University College London on June 17, 2011, at the Centre for Rheumatology of the Royal Free Hospital will review the the past 30 years of endothelial biology research. Speakers will include Sir Salvador Moncada, Dr. Gabor Rubanyi, and Dr. Jeremy Pearson, Associate Medical Director of the British Heart Foundation.

New Book on Endothelin in Renal Physiology and Medicine published
A new book is available discussing the role of endothelin and endothelin antagonists in kidney physiology and disease with contributions by leading experts in the fields of molecular biology, pharmacology, physiology, pathophysiology, and medicine.

Research from University of Zurich broadens understanding of diabetes
A recent report published in "BBA Mechanisms of Disease" discussing new treatment modalities such as blocking endothelin in patients with diabetic nephropathy and proteinuria featured by the online journal Biotech Week

2010

The Paul M. Vanhoutte Research Symposium at the Fourth Scientific Meeting of the ASVB, Hong Kong
This international meeting will be held on November 21, 2010 at the Fourth Scientific Meeting of the Asian Society of Vascular Biology at the University of Hong Kong, China, in the honor of Dr. Paul M. Vanhoutte's 70th birthday. Fifteen former students and fellows of Dr. Vanhoutte will present personal reflections on their mentor (more on page 18).


12th International Meeting on Vascular Neuroeffector Mechanisms, World Congress of Pharmacology, Odense
An international meeting will be held July 24-26, 2010, at Odense, Denmark, discussing novel aspects of vascular regulation in health and disease. A special session will be devoted to the role of obesity and the metabolic syndrome.

"Endothelin - Still Beyond Reach" Published in Massachusetts General Hospital's PROTO Magazine, Boston
An in-depth article by science writer Rachael Moeller-Gorman in the February 2010 issue of "PROTO Magazine" on the current state of endothelin research. The link also contains a pdf document available for download.

Recent findings in atherosclerosis described by researchers from University of Zurich
A recent article published in "Pfluger's Archive" on the effects of obesity and aging on endothelium-dependent regulation of vascular tone and its importance for disease development and therapy featured by the online journal "Obesity, Fitness & Wellness Week".

Researcher from University of Zurich describe findings on endothelin
A recent article published in "Pharmacology" reporting inhibitory effects of activation of the novel estrogen receptor GPR30/GPER on endothelin-mediated coronary vasoconstriction featured by the online journal "Biotech Week".

2009

Postmenopausal Hypertension Highlight at the American Heart Association's Annual Scientific Sessions, Orlando
An report by the American Heart Association on clinical importance and research of hypertension in women featured in a highlight event at the American Heart Association´s 82
nd Scientific Sessions 2009 in Orlando, FL.


ET-11 - The Eleventh International Conference on Endothelin, Montréal
The Eleventh International Conference on Endothelin will be held in Montréal, Canada, September 9-12, 2009. The newest in basic and clinical research in the field of endothelin and endothelin receptor antagonism from around the world will be presented. For more information see here

The American Physiological Society 2009 Gender Conference, Denver
At the 2009 APS Conference "Sex Steroids and Gender in Cardiovascular-Renal Physiology and Pathophysiology" to be held in Denver, CO, scientists and physicians will discuss the role of sex steroids in physiology and diseases related to the cardiovascular and renal system. A special session will be devoted to obesity and the metabolic syndrome.

The 4th Congress of the International Society of Gender Medicine, Berlin
Issues related to gender medicine, including vascular disease and the role of novel estrogen receptors, will be discussed among participants from around the world.

PBS/DGP Joint Meeting on "New Drugs in Cardiovascular Research", Dresden
The first Joint Meeting of the British Pharmacological Society and the Deutsche Gesellschaften für Experimentelle und Klinische Pharmakologie will be held in Dresden, Germany, May 7-9, 2009

Article on Importance of Endothelin Antagonist Therapy for Patients with Pulmonary Hypertension
An article published in "Medicals News Today" on the developments of endothelin antagonists for PAH in clinical medicine.

Report on New Estrogen Receptor receives the 2009 "Circulation Research" Best Manuscript Award
The article "Regulatory role of G protein-coupled estrogen receptor for vascular function and obesity" received the "Best Manuscript Award" from the editors of Circulation Research, one of the world´s leading journals in cardiovascular medicine and official journal of the American Heart Association. The award was presented at the American Heart Association´s 82nd Scientific Sessions in Orlando, FL.


2008

The 62nd Annual Fall Conference and Scientific Sessions of the AHA Council for High Blood Pressure Research
Summary by Dr. Clinton Webb, Program Chair, American Heart Association, Council for High Blood Pressure Research on the meeting and the workshop "Novel Signaling Paradigms in Vascular and Renal Disease".


SNF-Funded Research on Childhood Obesity Featured as "175 Jahre Universität Zürich" Research Highlight"
Childhood obesity is rising around the world. Featured article in German "Ist Dicksein eine Krankheit?" ( "Is obesity a disease?") by Swiss journalist Paula Lanfranconi about the causes and consequences of obesity in children and adults.

Researchers from University of Zurich detail new studies and findings in the area of obesity
A recent report published in "The Amercian Journal of Physiology" identifies the role of hydroxyl radical as a novel regulator of vascular function in obesity featured by the online journal Health & Medicine Week

The 1st International Conference on Drug Design & Discovery to be held in Dubai
This international drug discovery conference, sponsored by the Swiss National Science Foundation, will be held in Dubai, United Arabic Emirates, Februrary 4-7. 2008

New research published on endothelin provides insights into proteomics
A recent report on endothelin published in the "Canadian Journal of Physiology and Pharmacology" featured by the online journal "Heart Disease Weekly".

Special Congress on the "Aging Kidney" (Giornate Nefrologiche Romane 2008), Rome
A special meeting related to physiology, pathophysiology and treatment with regard to aging and renal disease will be held in Rome, Italy.

Clinical Report featured by HighBeam business on article published on 20 years of endothelin research
Report published in "Canadian Journal of Physiology and Pharmacology" featured by HighBeam business, a producer of teaching and research solutions for libraries and academic markets worldwide

2007

The American Physiological Society 2007 Gender Conference in Austin
At the 2007 APS Conference "Sex Steroids and Gender in Cardiovascular-Renal Physiology and Pathophysiology" to be held in Austin, TX, scientists and physicians will discuss the role of sex steroids in physiology and diseases related to the cardiovascular and renal system. A special session will be devoted to novel roles of estrogen receptors in cardiovascular disease.


ET-10 - The Tenth International Conference on Endothelin, Bergamo
The Tenth International Conference on Endothelin will be held in Bergamo, Italy, September 16-19, 2007. The newest in basic and clinical research in the field of endothelin and endothelin receptor antagonism from around the world will be presented. For more information see here

Nitric Oxide Mainz 2007 - The 12th NO Forum of the German-Speaking Countries in Mainz
At the Mainz 2007 Nitric Oxide meeting organized by Dr. Ulrich Forstermann and colleagues to be held in Mainz, Germany, scientists and physicians will discuss the role of nitric oxide in endothelial biology and diseases related to the cardiovascular and renal system.


New Data from University of Zurich on GPR30 Research in Atherosclerosis
An article from "Women´s Health Law Weekly" from August 2007 on the first report of the new estrogen receptor GPR30/GPER in arteries of patients with atherosclerosis published in the American Heart Association's Journal "Hypertension".

2006

Is "hormone therapy" really an option to achieve "anti-aging" ? Article on healthy aging
An article in German by Swiss journalist Paula Lanfranconi in University of Zurich's UNIMAGAZIN about the pros and cons of hormone therapy in aging individuals and options to achieve healthy aging.


Is it true that ... obesity is a disease? Article in Zurich University's "Unijournal"
An article in German by Swiss journalist Paula Lanfranconi discussing the causes and health risks of obesity in children and adults (page 20).


2005

Article on report showing upregulation of ETB receptors after ERA treatment in diabetes
An article published in "Fitness and and Wellness Business Week" on the first report showing counterregulation of endothelin receptors by ERA therapy.


ET-9 - The Ninth International Conference on Endothelin, Park City
The Ninth International Conference on Endothelin will be held in Park City, U.S.A. September 11-14, 2006. The newest in basic and clinical research in the field of endothelin and endothelin receptor antagonism from around the world will be presented. For more information see here

MIMED doctorate student receives ELITE-Med Award
Report in German published in the Neue Zürcher Zeitung on the presentation of the 2005 Elite-med Award created by Hans and Wilhelm Vetter.

2004

Scientific Mentoring as an indicator of long-term academic success in medicine
Website of the German Gesellschaft für angewandte Metaforschung, Erlangen, an association dedicated to evaluating and identifying the most influential individuals in different medical disciplines in Germany, Austria, and Switzerland, and their impact on the long-term academic success of junior scientists.


2003

Obesity Survival and Mortality
An article published in "Obesity and Diabetes Week" discusses the relationship between the renin-angiotensin system, endothelin and the increased mortality attributed to obesity.


ISOH'03-3rd International Symposium on Obesity and Hypertension "Genetics&Molecular Mechanisms", Berlin
An international meeting on obesity and hypertension was held on October 23-25, 2003 at Max-Dellbrück Center for Molecular Medicine in Berlin-Buch with 250 attendees from 54 countries from around the world. The meeting has been summarized here



2002

Citation rankings in cardiovascular research in German-speaking countries 1997-1999 according to ISI Philadelphia
Article published in the German «Laborjournal» presenting analyses of citation frequency of original research in cardiovascular research in German-speaking countries


2001

Citation rankings in physiology in German-speaking countries 1997-1999 according to ISI Philadelphia
Article published in the German «Laborjournal» presenting analyses of citation frequency of original research in physiology in German-speaking countries.